Page results
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
The lung function unit is an integral part of the department of Thoracic Medicine, offering a wide range of physiological tests to both inpatients and clinic outpatients within the Trust, to help not only in the diagnoses of lung disorders, but also to assess the severity of these conditions.
-
The department of Thoracic Medicine at UCH has particular expertise in the management of patients with bronchiectasis and respiratory infections (including fungal disease, lung abscess and opportunistic infections).
-
Out-patient IV antibiotic service
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
Information on safer eating during treatment, for patients with blood cancer.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
File results
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs
-
FOI/2024/0509 - Structure chart for Estates and Facilities
-
FOI/2024/0506 - Permanent/ fixed-term/ international recruitment
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0327 - Treatment of non-UK nationals